SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing heavy selling pressure as investors react to a significant equity financing plan designed to fund a massive backlog of AI server orders. While some community members view the dilution as a necessary step to support aggressive growth, others are expressing deep skepticism and frustration regarding management's transparency and historical execution.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is surging following a positive Q1 update and the rollout of the "Fermi 2.0" strategic plan, which has ignited investor optimism regarding imminent tenant signings. Community sentiment remains highly divided between speculative bulls anticipating a rerating upon contract confirmation and wary traders skeptical of governance turmoil and past management disputes.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO Inc. is trending as investors debate whether the current price represents a deep value buying opportunity or a long-term trap, with community sentiment split between frustration over persistent dilution and confidence in CEO Brad Jacobs' ability to execute a long-term platform roll-up strategy. Shareholders are closely watching upcoming earnings, key acquisition updates, and the impact of broader housing sector volatility as the stock faces continued pressure from short sellers and negative macroeconomic sentiment.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors grapple with shifting macroeconomic signals, including sticky inflation data and uncertainty surrounding potential Fed interest rate policy. The community is actively debating gold's role as a safe haven amid geopolitical tensions and contrasting performance against broader market assets like tech stocks and Bitcoin.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant market attention as investors weigh its aggressive AI infrastructure build-out against heavy capital expenditures, with the community debating whether the company's record backlog will successfully convert into long-term cloud revenue. Traders are aggressively positioning ahead of earnings, reflecting a volatile mix of high-conviction bullish sentiment and skepticism regarding the debt-funded strategy.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is seeing intense community debate and volatility, driven largely by speculation regarding potential subscription growth from upcoming global soccer events and recurring rumors about a possible Disney-related bundle. Investors remain deeply divided, with many expressing frustration over persistent management criticism and ongoing price weakness, while others point to low short interest coverage and oversold technicals as catalysts for a potential rebound.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 ETF is seeing heightened volatility as traders weigh persistent inflationary pressures against aggressive downside positioning, with community sentiment split between technical setups for a potential correction and speculation surrounding geopolitical de-escalation catalysts. Investors are actively debating the sustainability of current valuations, closely watching key options walls and institutional hedging flow for signs of whether this represents a structural rotation or the early phase of a broader market shift.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing heavy volatility and intense debate as the community reacts to ongoing military escalation in the Strait of Hormuz and a recent uptick in national inflation data. Traders and critics alike are actively dissecting the company's merger progress and its correlation with geopolitical developments, while the stock continues to see significant downward pressure amid broader market skepticism.

Cartesian Growth Corp III is a blank-check company that is sponsored by Cartesian Capital Group LLC. The company aims to acquire or merge with an established, high-growth business seeking access to public markets and capital. The company provides financial and operational expertise post-combination.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy is attracting intense investor attention driven by its low float and progress in solid-state battery technology, specifically its partnerships with major automotive manufacturers. The community is actively debating the stock's potential for volatile price swings, with many discussing the impact of upcoming filings and the technical outlook for the shares.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel stock is seeing heavy volatility and significant downward pressure following disappointing quarterly results and a lowered full-year outlook. The community remains sharply divided, with some investors betting on a potential short squeeze due to high short interest and deep undervaluation, while others argue the business faces structural decline and poor management execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Xeris Biopharma (XERS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Xeris Biopharma Reports First Quarter 2026 Financial Results

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...

Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction on Friday, May 1st. The stock was sold at an average price of $6.23, for a total value of $103,835.41. Following the sale, the insider directly owned 1,193,173...

Xeris Biopharma (XERS) to Release Earnings on Thursday

Xeris Biopharma (NASDAQ:XERS) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-xeris-pharmaceuticals-inc-stock...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) has earned an average rating of "Moderate Buy" from the seven research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy r...

Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL trimmed its stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 83.1% during the third quarter, according to its most recent filing with the Securities...

Apella Capital LLC Acquires 235,897 Shares of Xeris Biopharma Holdings, Inc. $XERS

Apella Capital LLC increased its holdings in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 2,359.0% during the fourth quarter, according to the company in its most recent...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the business's stock in a transaction on Wednesday, April 1st. The shares were sold at an...

Xeris Biopharma (NASDAQ:XERS) Insider Sells $99,835.33 in Stock

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at...

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Current Price	$6.72
Prev Close	$6.50
Open	$6.52
Dividend Yield	0.00%
50-Day Moving Average	$6.14
Beta	1.26
Avg. Volume	1.79M
PE Ratio	99.24

52-Week High	$10.08
52-Week Low	$4.30
Market Capitalization	$1.12B
EPS (Annual)	$0.0032
Price to Book	86.21
Revenue Per Employee	$670,908.05

XERSXeris Biopharma Holdings Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XERS News